wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38444096-7DC24074-2585-4A80-B287-14D0862C50E0
Q38444096-7DC24074-2585-4A80-B287-14D0862C50E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38444096-7DC24074-2585-4A80-B287-14D0862C50E0
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.
P2860
Q38444096-7DC24074-2585-4A80-B287-14D0862C50E0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38444096-7DC24074-2585-4A80-B287-14D0862C50E0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
891309e5b6574d552749e2602def3f7a3418970b
P2860
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).